Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression

Fig. 3

Levels of urinary angiostatin reflect disease specificity and severity. a. Levels of urinary angiostatin in the confirmation set and validation set. Levels of urinary angiostatin/Cr in the validation set. (When compared with healthy controls and disease controls: ***P and ###P < 0.001). b. Levels of urinary angiostatin/Cr in IgAN patients with different CKD stages, Lee’s grades, mesangial proliferative and tubular atrophy, and interstitial fibrosis change scores (compared with CKD stage 1, Lee’s grade IV-V, M0, and T0, respectively; **P < 0.01 and ***P < 0.001). c. Spearman correlation analysis of urinary angiostatin/Cr levels with proteinuria levels, serum creatinine, eGFR in IgAN patients

Back to article page